Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALBO

Albireo Pharma (ALBO) Stock Price, News & Analysis

Albireo Pharma logo

About Albireo Pharma Stock (NASDAQ:ALBO)

Advanced Chart

Key Stats

Today's Range
$43.99
$44.90
50-Day Range
$43.50
$44.95
52-Week Range
$16.02
$45.23
Volume
1.24 million shs
Average Volume
704,539 shs
Market Capitalization
$913.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Albireo Pharma and its competitors with MarketBeat's FREE daily newsletter.

ALBO Stock News Headlines

Prospect Park II in Fort Lauderdale
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
ALBO Historical Data
ALBO Albireo Pharma, Inc.
Albireo Pharma, Inc. (ALBO)
See More Headlines

ALBO Stock Analysis - Frequently Asked Questions

Albireo Pharma, Inc. (NASDAQ:ALBO) posted its quarterly earnings results on Thursday, November, 4th. The biopharmaceutical company reported $2.90 earnings per share for the quarter, topping the consensus estimate of ($0.38) by $3.28. The biopharmaceutical company earned $3.66 million during the quarter, compared to analysts' expectations of $22.33 million. Albireo Pharma had a negative trailing twelve-month return on equity of 97.13% and a negative net margin of 228.51%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Albireo Pharma investors own include Cuisine Solutions (CUSI), InnerScope Hearing Technologies (INND), Gilead Sciences (GILD), Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Corning (GLW) and Devon Energy (DVN).

Company Calendar

Last Earnings
11/04/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ALBO
CIK
1322505
Employees
130
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
($6.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$34.03 million
Net Margins
-228.51%
Pretax Margin
-235.11%
Return on Equity
-97.13%
Return on Assets
-46.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.32
Quick Ratio
6.23

Sales & Book Value

Annual Sales
$40.58 million
Price / Sales
22.52
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.11 per share
Price / Book
4.85

Miscellaneous

Outstanding Shares
20,700,000
Free Float
19,273,000
Market Cap
$913.91 million
Optionable
Optionable
Beta
1.03

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:ALBO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners